These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16971940)

  • 1. Tumour biology: Policing of oncogene activity by p53.
    Efeyan A; Garcia-Cao I; Herranz D; Velasco-Miguel S; Serrano M
    Nature; 2006 Sep; 443(7108):159. PubMed ID: 16971940
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer biology: can less be more for p53?
    Berns A
    Nature; 2006 Sep; 443(7108):153-4. PubMed ID: 16971934
    [No Abstract]   [Full Text] [Related]  

  • 3. The ARF tumour suppressor.
    Gallagher SJ; Kefford RF; Rizos H
    Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the tumor suppressor ARF in oncogenesis].
    Pimkina IuS; Dorosevich AE
    Arkh Patol; 2009; 71(1):60-3. PubMed ID: 19514363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the therapeutic efficacy of p53 restoration in tumors.
    Martins CP; Brown-Swigart L; Evan GI
    Cell; 2006 Dec; 127(7):1323-34. PubMed ID: 17182091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour suppression by p53: a role for the DNA damage response?
    Meek DW
    Nat Rev Cancer; 2009 Oct; 9(10):714-23. PubMed ID: 19730431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
    Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
    Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
    Moulin S; Llanos S; Kim SH; Peters G
    Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of p53-dependent senescence by the JNK signal transduction pathway.
    Das M; Jiang F; Sluss HK; Zhang C; Shokat KM; Flavell RA; Davis RJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15759-64. PubMed ID: 17893331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.
    Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN
    Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two wobble-splicing events affect ING4 protein subnuclear localization and degradation.
    Tsai KW; Tseng HC; Lin WC
    Exp Cell Res; 2008 Oct; 314(17):3130-41. PubMed ID: 18775696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage- and stress-induced apoptosis occurs independently of PIDD.
    Kim IR; Murakami K; Chen NJ; Saibil SD; Matysiak-Zablocki E; Elford AR; Bonnard M; Benchimol S; Jurisicova A; Yeh WC; Ohashi PS
    Apoptosis; 2009 Sep; 14(9):1039-49. PubMed ID: 19575295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 modulation of the DNA damage response.
    Helton ES; Chen X
    J Cell Biochem; 2007 Mar; 100(4):883-96. PubMed ID: 17031865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is p53 a key to understanding the distinction of aging process between normal human and rodent cells?
    Lim CS
    Med Hypotheses; 2006; 67(1):191. PubMed ID: 16545916
    [No Abstract]   [Full Text] [Related]  

  • 17. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
    Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
    J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression.
    Ewings KE; Ryan KM
    Cell Res; 2007 Oct; 17(10):829-31. PubMed ID: 17934491
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryptic mitochondrial targeting signals in human ARF: clues to controlling cancer?
    Henderson BR
    Cell Cycle; 2010 Mar; 9(5):866-7. PubMed ID: 20348846
    [No Abstract]   [Full Text] [Related]  

  • 20. Celebrating 30 years of p53 research.
    Hosking CR
    Trends Cell Biol; 2010 Jan; 20(1):1. PubMed ID: 19959362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.